Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies advance toward broader commercial adoption, the industry faces mounting pre...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
Taiwan-based startup TFBS Bioscience, Inc. and Australia's QIMR Berghofer Medical Research Institute have jointly announ...
Charles River Laboratories has announced a new collaboration with MEDIPOST, Inc. focused on advancing Good Manufacturing...
New platform leverages the established Curator® platform methodology to industrialize Lentivirus processes from conc...
BioOra Limited, a New Zealand-based company pioneering automated, cost-effective CAR T-cell manufacturing, has announced...
South Korea’s CGT ecosystem is diverse and expanding, with a good mix of both early-stage startups, large pharma c...
Andelyn Biosciences, a US-based cell and gene therapy Contract Development and Manufacturing Organization (CDMO), and EN...
BioOra Limited, a commercial-stage cell therapy company advancing CAR-T therapies for cancer patients, and Canada-based ...
US-based RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioproc...
US-based Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™ CTS™ Compleo&trade...
How does this facility differ from your earlier collaborations, such as the one with the Bangalore Bioinnovation Centre ...
According to Cytiva’s 2025 Global Biopharma Index, more than one-third of the 1,250 industry leaders surveyed repo...
AstraZeneca has announced plans to establish a commercial cell therapy manufacturing and supply base and innovation cent...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
Achondroplasia, the most common form of genetic dwarfism, has historically relied on treatment approaches that require f...
In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Cyto-Fa...
Cell and gene therapies are transforming the therapeutic landscape, offering the potential to treat prev...
Opening the keynote session of the APAC Biomanufacturing Leadership Summit 2026, Pengfei Chen highlighted the rapid tran...
Terumo Blood and Cell Technologies (Terumo BCT) has announced the launch of its new cell & gene therapy (C&...
Offering scalable quality grades from Research to GMP, PlasmidFactory supports advanced gene-based innovations worldwide...
